User menu

Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?

Bibliographic reference Tombal, Bertrand ; Lecouvet, Frédéric. Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?. In: Advances in Urology, Vol. 2012, p. 893193 [1-8] (2012)
Permanent URL
  1. Ferlay Jacques, Shin Hai-Rim, Bray Freddie, Forman David, Mathers Colin, Parkin Donald Maxwell, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, 10.1002/ijc.25516
  2. Verhagen Paul C.M.S., Schröder Fritz H., Collette Laurence, Bangma Chris H., Does Local Treatment of the Prostate in Advanced and/or Lymph Node Metastatic Disease Improve Efficacy of Androgen-Deprivation Therapy? A Systematic Review, 10.1016/j.eururo.2010.05.027
  3. Journal of Urology, 168, 1423 (2002)
  4. Soloway Mark S., Hardeman Stephen W., Hickey David, Todd Barbara, Soloway Scott, Raymond Jane, Moinuddin Mohammed, Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan, 10.1002/1097-0142(19880101)61:1<195::aid-cncr2820610133>;2-y
  5. Nørgaard Mette, Jensen Annette Østergaard, Jacobsen Jacob Bonde, Cetin Kara, Fryzek Jon P., Sørensen Henrik Toft, Skeletal Related Events, Bone Metastasis and Survival of Prostate Cancer: A Population Based Cohort Study in Denmark (1999 to 2007), 10.1016/j.juro.2010.03.034
  6. Loberg Robert D., Logothetis Christopher J., Keller Evan T., Pienta Kenneth J., Pathogenesis and Treatment of Prostate Cancer Bone Metastases: Targeting the Lethal Phenotype, 10.1200/jco.2005.03.0841
  7. Smith Matthew R., Cook Richard J., Coleman Robert, Brown Janet, Lipton Allan, Major Pierre, Hei Yong Jiang, Saad Fred, Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer, 10.1016/j.urology.2007.03.071
  8. 1 (2011)
  9. Guidelines on prostate cancer (2010)
  10. Scher Howard I., Halabi Susan, Tannock Ian, Morris Michael, Sternberg Cora N., Carducci Michael A., Eisenberger Mario A., Higano Celestia, Bubley Glenn J., Dreicer Robert, Petrylak Daniel, Kantoff Philip, Basch Ethan, Kelly William Kevin, Figg William D., Small Eric J., Beer Tomasz M., Wilding George, Martin Alison, Hussain Maha, Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group, 10.1200/jco.2007.12.4487
  11. Therasse P, Measuring the clinical response. What does it mean?, 10.1016/s0959-8049(02)00182-x
  12. Therasse Patrick, Arbuck Susan G., Eisenhauer Elizabeth A., Wanders Jantien, Kaplan Richard S., Rubinstein Larry, Verweij Jaap, Van Glabbeke Martine, van Oosterom Allan T., Christian Michaele C., Gwyther Steve G., New Guidelines to Evaluate the Response to Treatment in Solid Tumors, 10.1093/jnci/92.3.205
  13. Aus Gunnar, Bergdahl Svante, Lodding Pär, Lilja Hans, Hugosson Jonas, Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized Controlled Trial, 10.1016/j.eururo.2006.07.012
  14. RANA A., KARAMANIS K., LUCAS M. G., CHISHOLM G. D., Identification of Metastatic Disease by T Category, Gleason Score and Serum PSA Level in Patients with Carcinoma of the Prostate, 10.1111/j.1464-410x.1992.tb15528.x
  15. Briganti Alberto, Passoni Niccolò, Ferrari Matteo, Capitanio Umberto, Suardi Nazareno, Gallina Andrea, Pozzo Luigi Filippo Da, Picchio Maria, Di Girolamo Valerio, Salonia Andrea, Gianolli Liugi, Messa Cristina, Rigatti Patrizio, Montorsi Francesco, When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool , 10.1016/j.eururo.2009.12.023
  16. Thompson Ian, Thrasher James Brantley, Aus Gunnar, Burnett Arthur L., Canby-Hagino Edith D., Cookson Michael S., D’Amico Anthony V., Dmochowski Roger R., Eton David T., Forman Jeffrey D., Goldenberg S. Larry, Hernandez Javier, Higano Celestia S., Kraus Stephen R., Moul Judd W., Tangen Catherine M., Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update, 10.1016/j.juro.2007.03.003
  17. Gomez Pablo, Manoharan Marugesan, Kim Sandy S., Soloway Mark S., Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?, 10.1111/j.1464-410x.2004.04927.x
  18. Pound Charles R., Natural History of Progression After PSA Elevation Following Radical Prostatectomy, 10.1001/jama.281.17.1591
  19. Choueiri Toni K., Dreicer Robert, Paciorek Alan, Carroll Peter R., Konety Badrinath, A Model That Predicts the Probability of Positive Imaging in Prostate Cancer Cases With Biochemical Failure After Initial Definitive Local Therapy, 10.1016/j.juro.2007.10.059
  20. Smith Matthew R., Kabbinavar Fairooz, Saad Fred, Hussain Arif, Gittelman Marc C., Bilhartz David L., Wynne Chris, Murray Robin, Zinner Norman R., Schulman Claude, Linnartz Ronald, Zheng Ming, Goessl Carsten, Hei Yong-Jiang, Small Eric J., Cook Richard, Higano Celestia S., Natural History of Rising Serum Prostate-Specific Antigen in Men With Castrate Nonmetastatic Prostate Cancer, 10.1200/jco.2005.01.529
  21. Smith Matthew R., Cook Richard, Lee Ker-Ai, Nelson Joel B., Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer, 10.1002/cncr.25762
  22. Condon B. R., Buchanan R., Garvie N. W., Ackery D. M., Fleming J., Taylor D., Hawkes D., Goddard B. A., Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging, 10.1259/0007-1285-54-637-18
  23. Pollen Jeffrey J., Gerber Kenneth, Ashburn William L., Schmidt Joseph D., Nuclear bone imaging in metastatic cancer of the prostate, 10.1002/1097-0142(19810601)47:11<2585::aid-cncr2820471113>;2-u
  24. Einhorn Thomas A., Vigorita Vincent J., Aaron Alan, Localization of technetium-99m methylene diphosphonate in bone using microautoradiography, 10.1002/jor.1100040206
  25. Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka J T, Melhem E R, Yucel E K, A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases., 10.2214/ajr.169.6.9393186
  26. Hamaoka Tsuyoshi, Madewell John E., Podoloff Donald A., Hortobagyi Gabriel N., Ueno Naoto T., Bone Imaging in Metastatic Breast Cancer, 10.1200/jco.2004.08.181
  27. Quarterly Journal of Nuclear Medicine, 45, 53 (2001)
  28. Daldrup-Link Heike E., Franzius Christiane, Link Thomas M., Laukamp Daniela, Sciuk Joachim, Jürgens Heribert, Schober Otmar, Rummeny Ernst J., Whole-Body MR Imaging for Detection of Bone Metastases in Children and Young Adults : Comparison with Skeletal Scintigraphy and FDG PET, 10.2214/ajr.177.1.1770229
  29. Jacobson Arnold F., Fogelman Ignac, Bone scanning in clinical oncology: does it have a future?, 10.1007/s002590050287
  30. Journal of Nuclear Medicine, 40, 1623 (1999)
  31. Journal of Nuclear Medicine, 34, 2191 (1993)
  32. McKillop J H, McDougall I R, The role of skeletal scanning in clinical oncology., 10.1136/bmj.281.6237.407
  33. Venkitaraman Ramachandran, Sohaib Aslam, Cook Gary, MRI or Bone Scan or Both for Staging of Prostate Cancer?, 10.1200/jco.2007.14.3875
  34. Journal of Nuclear Medicine, 42, 1800 (2001)
  35. Han L. J., Au-Yong T. K., Tong W. C. M., Chu K. S., Szeto L. T., Wong C. P., Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain, 10.1007/s002590050266
  36. Journal of Nuclear Medicine, 47, 287 (2006)
  37. Nozaki Tetsuo, Yasuda Kenji, Akashi Takuya, Fuse Hideki, Usefulness of single photon emission computed tomography imaging in the detection of lumbar vertebral metastases from prostate cancer : Bone SPECT in metastatic prostate cancer, 10.1111/j.1442-2042.2008.02028.x
  38. Helyar Vincent, Mohan Hosahalli K., Barwick Tara, Livieratos Lefteris, Gnanasegaran Gopinath, Clarke Susan E. M., Fogelman Ignac, The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate, 10.1007/s00259-009-1334-3
  39. Schirrmeister Holger, Guhlmann Albrecht, Kotzerke Jörg, Santjohanser Claudia, Kühn Thorsten, Kreienberg Rolf, Messer Peter, Nüssle Karin, Elsner Klaus, Glatting Gerhard, Träger Harald, Neumaier Bernd, Diederichs Christoph, Reske Sven N., Early Detection and Accurate Description of Extent of Metastatic Bone Disease in Breast Cancer With Fluoride Ion and Positron Emission Tomography, 10.1200/jco.1999.17.8.2381
  40. Schirrmeister Holger, Kühn Thorsten, Guhlmann Albrecht, Santjohanser Claudia, Hörster Thomas, Nüssle Karin, Koretz Karin, Glatting Gerhard, Rieber Andrea, Kreienberg Rolf, Buck Andreas C, Reske Sven N, Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures, 10.1007/s002590000448
  41. Uematsu Takayoshi, Yuen Sachiko, Yukisawa Seigo, Aramaki Takeshi, Morimoto Naoki, Endo Masahiro, Furukawa Hiroyoshi, Uchida Yoshihiro, Watanabe Junichiro, Comparison of FDG PET and SPECT for Detection of Bone Metastases in Breast Cancer, 10.2214/ajr.184.4.01841266
  42. Ghanem N., Uhl M., Brink I., Schäfer O., Kelly T., Moser E., Langer M., Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone, 10.1016/j.ejrad.2005.01.016
  43. Cancer, 88, 2927 (2000)
  44. Eschmann Susanne Martina, Pfannenberg Anna, Rieger Andre, Aschoff Phillipp, Müller Mark, Paulsen Frank, Anastasiadis Aristotelis, Claussen Claus, Bares Roland, Schlemmer Heinz, Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer : , 10.1160/nukmed-0075
  45. NuklearMedizin, 42, 25 (2003)
  46. Yu Evan Y., Muzi Mark, Hackenbracht Joy A., Rezvani Brian B., Link Jeanne M., Montgomery Robert Bruce, Higano Celestia S., Eary Janet F., Mankoff David A., C11-Acetate and F-18 FDG PET for Men With Prostate Cancer Bone Metastases : Relative Findings and Response to Therapy, 10.1097/rlu.0b013e318208f140
  47. Beheshti Mohsen, Vali Reza, Waldenberger Peter, Fitz Friedrich, Nader Michael, Loidl Wolfgang, Broinger Gabriele, Stoiber Franz, Foglman Ignac, Langsteger Werner, Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET–CT: a comparative study, 10.1007/s00259-008-0788-z
  48. Beheshti Mohsen, Vali Reza, Waldenberger Peter, Fitz Friedrich, Nader Michael, Hammer Josef, Loidl Wolfgang, Pirich Christian, Fogelman Ignac, Langsteger Werner, The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT, 10.1007/s11307-009-0239-7
  49. Eschmann Susanne Martina, Pfannenberg Anna, Rieger Andre, Aschoff Phillipp, Müller Mark, Paulsen Frank, Anastasiadis Aristotelis, Claussen Claus, Bares Roland, Schlemmer Heinz, Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer : , 10.1160/nukmed-0075
  50. Groves Ashley M., Beadsmoore Clare J., Cheow Heok K., Balan Kottekkattu K., Courtney Helen M., Kaptoge Stephen, Win Thida, Harish Srinivasan, Bearcroft Philip W. P., Dixon Adrian K., Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient, 10.1007/s00330-005-0042-z
  51. Daffner RH, Lupetin AR, Dash N, Deeb ZL, Sefczek RJ, Schapiro RL, MRI in the detection of malignant infiltration of bone marrow, 10.2214/ajr.146.2.353
  52. Sanal S M, Flickinger F W, Caudell M J, Sherry R M, Detection of bone marrow involvement in breast cancer with magnetic resonance imaging., 10.1200/jco.1994.12.7.1415
  53. Traill ZoëC, Talbot Denis, Golding Stephen, Gleeson Fergus V, Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases, 10.1016/s0009-9260(99)90830-9
  54. Frank J A, Ling A, Patronas N J, Carrasquillo J A, Horvath K, Hickey A M, Dwyer A J, Detection of malignant bone tumors: MR imaging vs scintigraphy., 10.2214/ajr.155.5.2120933
  55. European Journal of Nuclear Medicine, 20, 1063 (1993)
  56. Skeletal Radiology, 19, 113 (1990)
  57. Tombal Bertrand, Rezazadeh Afshin, Therasse Patrick, Van Cangh Paul J., Vande Berg Bruno, Lecouvet Frédéric E., Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases, 10.1002/pros.20280
  58. Vande Berg B. C., Lecouvet F. E., Michaux L., Ferrant A., Maldague B., Malghem J., Magnetic resonance imaging of the bone marrow in hematological malignancies, 10.1007/s003300050548
  59. Vande Berg Bruno C., Malghem Jacques, Lecouvet Frederic E., Maldague Baudouin, Magnetic resonance imaging of the normal bone marrow, 10.1007/s002560050423
  60. Vanel D., Bittoun J., Tardivon A., MRI of bone metastases, 10.1007/s003300050549
  61. Journal of Urology, 149, 1482 (1993)
  62. Walker R., Kessar P., Blanchard R., Dimasi M., Harper K., DeCarvalho V., Yucel E.K., Patriquin L., Eustace S., Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience, 10.1002/(sici)1522-2586(200004)11:4<343::aid-jmri1>;2-p
  63. Lecouvet Frédéric E., Geukens Daphné, Stainier Annabelle, Jamar François, Jamart Jacques, d'Othée Bertrand Janne, Therasse Patrick, Berg Bruno Vande, Tombal Bertrand, Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients With High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies, 10.1200/jco.2006.09.2940
  64. Lecouvet F. E., Simon M., Tombal B., Jamart J., Vande Berg B. C., Simoni P., Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa), 10.1007/s00330-010-1879-3
  65. Luboldt Wolfgang, Küfer Rainer, Blumstein Norbert, Toussaint Todd L., Kluge Alexander, Seemann Marcus D., Luboldt Hans-Joachim, Prostate Carcinoma: Diffusion-weighted Imaging as Potential Alternative to Conventional MR and C-Choline PET/CT for Detection of Bone Metastases, 10.1148/radiol.2492080038
  66. Venkitaraman R, Cook GJR, Dearnaley DP, Parker CC, Khoo V, Eeles R, Huddart RA, Horwich A, Sohaib SA, Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer, 10.1111/j.1754-9485.2009.02070.x
  67. Kwee Thomas C., Takahara Taro, Ochiai Reiji, Nievelstein Rutger A. J., Luijten Peter R., Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology, 10.1007/s00330-008-0968-z
  68. Vilanova Joan C., Barceló Joaquim, Diffusion-weighted whole-body MR screening, 10.1016/j.ejrad.2008.02.040